Cargando…

NAD(+) Precursors: A Questionable Redundancy

The last decade has seen a strong proliferation of therapeutic strategies for the treatment of metabolic and age-related diseases based on increasing cellular NAD(+) bioavailability. Among them, the dietary supplementation with NAD(+) precursors—classically known as vitamin B3—has received most of t...

Descripción completa

Detalles Bibliográficos
Autor principal: Canto, Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316858/
https://www.ncbi.nlm.nih.gov/pubmed/35888754
http://dx.doi.org/10.3390/metabo12070630
_version_ 1784754916797972480
author Canto, Carles
author_facet Canto, Carles
author_sort Canto, Carles
collection PubMed
description The last decade has seen a strong proliferation of therapeutic strategies for the treatment of metabolic and age-related diseases based on increasing cellular NAD(+) bioavailability. Among them, the dietary supplementation with NAD(+) precursors—classically known as vitamin B3—has received most of the attention. Multiple molecules can act as NAD(+) precursors through independent biosynthetic routes. Interestingly, eukaryote organisms have conserved a remarkable ability to utilize all of these different molecules, even if some of them are scarcely found in nature. Here, we discuss the possibility that the conservation of all of these biosynthetic pathways through evolution occurred because the different NAD(+) precursors might serve specialized purposes.
format Online
Article
Text
id pubmed-9316858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93168582022-07-27 NAD(+) Precursors: A Questionable Redundancy Canto, Carles Metabolites Review The last decade has seen a strong proliferation of therapeutic strategies for the treatment of metabolic and age-related diseases based on increasing cellular NAD(+) bioavailability. Among them, the dietary supplementation with NAD(+) precursors—classically known as vitamin B3—has received most of the attention. Multiple molecules can act as NAD(+) precursors through independent biosynthetic routes. Interestingly, eukaryote organisms have conserved a remarkable ability to utilize all of these different molecules, even if some of them are scarcely found in nature. Here, we discuss the possibility that the conservation of all of these biosynthetic pathways through evolution occurred because the different NAD(+) precursors might serve specialized purposes. MDPI 2022-07-09 /pmc/articles/PMC9316858/ /pubmed/35888754 http://dx.doi.org/10.3390/metabo12070630 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Canto, Carles
NAD(+) Precursors: A Questionable Redundancy
title NAD(+) Precursors: A Questionable Redundancy
title_full NAD(+) Precursors: A Questionable Redundancy
title_fullStr NAD(+) Precursors: A Questionable Redundancy
title_full_unstemmed NAD(+) Precursors: A Questionable Redundancy
title_short NAD(+) Precursors: A Questionable Redundancy
title_sort nad(+) precursors: a questionable redundancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316858/
https://www.ncbi.nlm.nih.gov/pubmed/35888754
http://dx.doi.org/10.3390/metabo12070630
work_keys_str_mv AT cantocarles nadprecursorsaquestionableredundancy